Foamix Pharmaceuticals Stock Price - FOMX

0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Foamix Pharmaceuticals Ltd FOMX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.14 3.32% 4.36 4.20 4.425 4.20 4.22 00:00:01
Bid Price Ask Price Spread Spread % News
3.85 4.80 0.95 19.79% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,089 177,379 $ 4.32 $ 765,605 597,213 1.97 - 4.9199
Last Trade Time Type Quantity Stock Price Currency
16:58:57 formt 2,060 $ 4.36 USD

Foamix Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 267.07M 61.25M $ -74.16M -1.73 - 60.60M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Foamix Pharmaceuticals News

Loading Messages....

Latest FOMX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FOMX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.284.554.124.31225,7870.081.87%
1 Month4.264.693.744.28432,9630.102.35%
3 Months3.164.91992.7453.77550,9611.2037.97%
6 Months2.904.91992.533.39943,8001.4650.34%
1 Year3.724.91991.973.25720,4610.6417.2%
3 Years10.2510.371.974.15427,682-5.89-57.46%
5 Years9.3014.001.975.19324,757-4.94-53.12%

Foamix Pharmaceuticals Description

Foamix Pharmaceuticals Ltd is a specialty pharmaceutical company. It is focused on the development and commercialization of foam based formulations and topical drugs for dermatological therapies mainly acne, rosacea and other skin conditions. Its product candidates include FMX101, FMX102, FMX103, FDX104. The firm also has development and license agreements relating to its technology with various pharmaceutical companies. It has The development and commercialization of foam based formulations segment.

Your Recent History
Foamix Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.